Arkolith/Insider Trading/MIST/Form 4

Oliveto Joseph

President and CEO, DirectorMilestone Pharmaceuticals Inc. (MIST) · full profile →Form 4 · filed Jan 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$98K
Net Open-Market Flow
-$98K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 8, 2026Sell(S)43K$2.25$97K304K
Jan 7, 2026Sell(S)500$2.25$1K347K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437782-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML